|
|
|
|
|
|
|
|
|||||
| Home Help Feedback Subscriptions Archive Search Table of Contents | |||||
Journal of Cell Science, Vol 109, Issue 10 2581-2590, Copyright © 1996 by Company of Biologists
JOURNAL ARTICLES |
SL Schor, I Ellis, C Dolman, J Banyard, MJ Humphries, DF Mosher, AM Grey, AP Mould, J Sottile and AM Schor
Department of Dental Surgery and Periodontology, Dental School, University of Dundee, UK.
Nanomolar concentrations of native fibronectin and its RGDS-containing cell-binding domain have previously been reported to stimulate fibroblast migration in the transmembrane (or 'Boyden chamber') assay; in contrast, the gelatin-binding domain (GBD) of fibronectin has consistently been reported to be devoid of migration-stimulating activity in this assay. We have examined the effects of fibronectin and several of its purified functional domains on the migration of human skin fibroblasts in what is presumably a more physiologically relevant assay involving the movement of cells into a 3-D matrix of native type I collagen fibrils. We report that: (a) femtomolar concentrations of GBD stimulate fibroblast migration into such collagen matrices; and (b) fibronectin, as well as peptides containing all other of its functional domains, do not exhibit migration-stimulating activity when tested in the femtomolar to nanomolar concentration range (i.e. 0.1 pg/ml to 1 microgram/ml). The correct assignment of migration-stimulating activity to GBD, rather than to a contaminant, was confirmed by: (a) the use of several fibronectin and GBD purification protocols; (b) the neutralization of GBD migration-stimulating activity by monoclonal antibodies directed against epitopes present in this domain; (c) the time-dependent generation of migration-stimulating activity by the proteolytic degradation of native fibronectin; and (d) obtaining an identical dose-response curve with a genetically engineered GBD peptide. The cryptic migration-stimulating activity of GBD was not affected by the presence of serum or native fibronectin, but was inhibited by TGF-beta 1. Parallel experiments using the transmembrane assay confirmed that GBD was devoid of migration-stimulating activity in this assay when membranes coated with gelatin were used, but revealed that significant stimulation of migration was achieved with membranes coated with native type I collagen. Cells preincubated with GBD for 24 hours whilst growing on plastic tissue culture dishes and then plated onto native collagen matrices in the absence of further GBD also displayed an elevated migration compared to controls. Taken together, these observations suggest that: (a) the interaction of GBD with a putative cell surface receptor (and not the collagen substratum) initiates a persistent alteration in cell phenotype which is manifest by an increase in migratory activity when these cells are cultured on a native collagen substratum; and (b) GBD may play a hitherto unrecognised role in the control of cell migration in response to the local release of proteases during pathological processes, such as tumour invasion and wound repair.
This article has been cited by other articles:
|
|
 |
|
  C. J. Millard, I. R. Ellis, A. R. Pickford, A. M. Schor, S. L. Schor, and I. D. Campbell The Role of the Fibronectin IGD Motif in Stimulating Fibroblast Migration J. Biol. Chem., December 7, 2007; 282(49): 35530 - 35535. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Tomkowicz, K. Rybinski, B. Foley, W. Ebel, B. Kline, E. Routhier, P. Sass, N. C. Nicolaides, L. Grasso, and Y. Zhou Interaction of endosialin/TEM1 with extracellular matrix proteins mediates cell adhesion and migration PNAS, November 13, 2007; 104(46): 17965 - 17970. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. L. Schor, I. R. Ellis, S. J. Jones, R. Baillie, K. Seneviratne, J. Clausen, K. Motegi, B. Vojtesek, K. Kankova, E. Furrie, et al. Migration-Stimulating Factor: A Genetically Truncated Onco-Fetal Fibronectin Isoform Expressed by Carcinoma and Tumor-Associated Stromal Cells Cancer Res., December 15, 2003; 63(24): 8827 - 8836. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Colombi, N. Zoppi, G. De Petro, E. Marchina, R. Gardella, D. Tavian, S. Ferraboli, and S. Barlati Matrix Assembly Induction and Cell Migration and Invasion Inhibition by a 13-Amino Acid Fibronectin Peptide J. Biol. Chem., April 11, 2003; 278(16): 14346 - 14355. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. R. Beals, A. C. Edwards, R. J. Gottschalk, T. W. Kuijpers, and D. E. Staunton CD18 Activation Epitopes Induced by Leukocyte Activation J. Immunol., December 1, 2001; 167(11): 6113 - 6122. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. E. Davis, K. J. Bayless, M. J. Davis, and G. A. Meininger Regulation of Tissue Injury Responses by the Exposure of Matricryptic Sites within Extracellular Matrix Molecules Am. J. Pathol., May 1, 2000; 156(5): 1489 - 1498. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. J. Langenbach and J. Sottile Identification of Protein-disulfide Isomerase Activity in Fibronectin J. Biol. Chem., March 12, 1999; 274(11): 7032 - 7038. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Schor, I Ellis, J Banyard, and A. Schor Motogenic activity of IGD-containing synthetic peptides J. Cell Sci., January 11, 1999; 112(22): 3879 - 3888. [Abstract] [PDF]
|
|
|
|
|
|
R. Christopher, S. Judge, P. Vincent, P. Higgins, and P. McKeown-Longo The amino-terminal matrix assembly domain of fibronectin stabilizes cell shape and prevents cell cycle progression J. Cell Sci., January 10, 1999; 112(19): 3225 - 3235. [Abstract] [PDF]
|
|
